L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic β-cells

被引:0
作者
Jaeyong Cho
Yukio Horikawa
Mayumi Enya
Jun Takeda
Yoichi Imai
Yumi Imai
Hiroshi Handa
Takeshi Imai
机构
[1] National Center for Geriatrics and Gerontology,Department Aging Intervention
[2] Gifu University,Department of Diabetes and Endocrinology
[3] University of Tokyo,Department of Hematology/Oncology, Research Hospital, Institute of Medical Science
[4] University of Iowa Carver College of Medicine,Department of Internal Medicine, Fraternal Order of Eagles Diabetes Research Center
[5] Tokyo Medical University,Department of Nanoparticle Translational Research
来源
Communications Biology | / 3卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We sought to determine a mechanism by which L-arginine increases glucose-stimulated insulin secretion (GSIS) in β-cells by finding a protein with affinity to L-arginine using arginine-immobilized magnetic nanobeads technology. Glucokinase (GCK), the key regulator of GSIS and a disease-causing gene of maturity-onset diabetes of the young type 2 (MODY2), was found to bind L-arginine. L-Arginine stimulated production of glucose-6-phosphate (G6P) and induced insulin secretion. We analyzed glucokinase mutants and identified three glutamate residues that mediate binding to L-arginine. One MODY2 patient with GCKE442* demonstrated lower C-peptide-to-glucose ratio after arginine administration. In β-cell line, GCKE442* reduced L-arginine-induced insulin secretion compared with GCKWT. In addition, we elucidated that the binding of arginine protects glucokinase from degradation by E3 ubiquitin ligase cereblon mediated ubiquitination. We conclude that L-arginine induces insulin secretion by increasing G6P production by glucokinase through direct stimulation and by prevention of degradation.
引用
收藏
相关论文
共 80 条
  • [1] Garcia-Herrero CM(2012)Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing PLoS ONE 7 e30518-712
  • [2] Horikawa Y(2018)Maturity-onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus J. Diabetes Investig. 9 704-86
  • [3] Molnes J(2011)Binding of ATP at the active site of human pancreatic glucokinase-nucleotide-induced conformational changes with possible implications for its kinetic cooperativity FEBS J. 278 2372-3009
  • [4] Markwardt ML(2016)Regulation of glucokinase by intracellular Calcium levels in pancreatic β cells J. Biol. Chem. 291 3000-973
  • [5] Seckinger KM(2017)The dynamic plasticity of insulin production in β-cells Mol. Metab. 6 958-S404
  • [6] Rizzo MA(2015)Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity Sci. Rep. 5 148-S64
  • [7] Boland BB(2019)The central role of glucokinase in glucose homeostasis: A perspective 50 years after demonstrating the presence of the enzyme in islets of Langerhans Front. Physiol. 10 S394-1705
  • [8] Rhodes CJ(2002)Regulation of pancreatic β-cell glucokinase: from basics to therapeutics Diabetes 51 S55-12194
  • [9] Grimsby JS(2006)Glucokinase regulatory network in pancreatic β-cells and liver Diabetes 55 1698-482
  • [10] Park JM(1999)Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia Diabetes 48 12189-1487